The buyback committee on Aug 27 approved the basis of acceptance of 5.67 cr shares of the face value of ₹10/- each; with this, Airtel’s shareholding in Indus has risen to over 50%
The pharma company has fixed floor price for share buyback at ₹1,460 per share, a premium of 6.4% over Tuesday's closing price of ₹1,371.70 on the BSE.
The board of L&T has approved the buyback of equity shares worth ₹10,000 crore at maximum price of up to ₹3,000 per share through the tender offer route.
The board of L&T approved the buyback of up to 3.33 crore equity shares worth ₹10,000 crore at ₹3,000 apiece, a premium of 17% from the current trading price.